Bioventus Q3 Adj EPS $0.05 Misses $0.06 Estimate, Sales $120.79M Beat $120.34M Estimate
Portfolio Pulse from mahesh@benzinga.com
Bioventus (NASDAQ:BVS) reported Q3 earnings of $0.05 per share, missing the analyst consensus estimate of $0.06 by 16.67%. This is a 37.5% decrease from the same period last year. However, the company's quarterly sales of $120.79 million beat the analyst consensus estimate of $120.34 million by 0.38%, despite being an 11.87% decrease from last year.
November 07, 2023 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bioventus reported lower than expected Q3 earnings and a decrease in sales from last year, which could negatively impact its stock price.
Bioventus reported a decrease in earnings and sales from the same period last year, and also missed the analyst consensus estimate for earnings. This could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100